abstract |
The present invention relates to a method for inhibiting bone metastasis, a method for preventing new metastatic growth, a method for inhibiting bone metabolic replacement, and a method for preventing bone loss, using an endothelin ET-A receptor antagonist, in patients including cancer patients will be. |